Here, we took advantage of in vitro ALS patient-specific, iPSCs-derived MNs carrying FUS mutations to delineate the direct impact of human Th17 cells and its main cytokine, IL17, on human MNs. The gene discussed is IL17A; the disease is amyotrophic lateral sclerosis.